AU2001267917A1 - Antipruritic compositions and compositions promoting wound healing - Google Patents

Antipruritic compositions and compositions promoting wound healing

Info

Publication number
AU2001267917A1
AU2001267917A1 AU2001267917A AU6791701A AU2001267917A1 AU 2001267917 A1 AU2001267917 A1 AU 2001267917A1 AU 2001267917 A AU2001267917 A AU 2001267917A AU 6791701 A AU6791701 A AU 6791701A AU 2001267917 A1 AU2001267917 A1 AU 2001267917A1
Authority
AU
Australia
Prior art keywords
composition
compositions
antipruritic
wound healing
sasa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001267917A
Inventor
Kenjirou Tsuchida
Kotarou Tsuchida
Yuuzou Tsuchida
Sumiaki Tsuru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2001267917A1 publication Critical patent/AU2001267917A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Birds (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

An antipruritic composition and a wound-healing-promoting composition which comprise Sasa albo-marginata (Bambooseae Sasa) extract in an amount ranging from 1 to 10% by mass as expressed in terms of the solid content thereof. The composition of the present invention comprises the Sasa albo-marginata extract in a concentration substantially higher than that observed for the conventional composition and accordingly, the composition shows high antipruritic effect against skin diseases such as atopy, which have conventionally been considered to be difficult to treat and/or alleviate and the composition likewise shows an excellent wound-healing-promoting effect.
AU2001267917A 2000-07-26 2001-07-03 Antipruritic compositions and compositions promoting wound healing Abandoned AU2001267917A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2000-224927 2000-07-26
JP2000-224926 2000-07-26
JP2000224927 2000-07-26
JP2000224926 2000-07-26
PCT/JP2001/005765 WO2002007745A1 (en) 2000-07-26 2001-07-03 Antipruritic compositions and compositions promoting wound healing

Publications (1)

Publication Number Publication Date
AU2001267917A1 true AU2001267917A1 (en) 2002-02-05

Family

ID=26596680

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001267917A Abandoned AU2001267917A1 (en) 2000-07-26 2001-07-03 Antipruritic compositions and compositions promoting wound healing

Country Status (10)

Country Link
US (2) US20030113387A1 (en)
EP (1) EP1304115B1 (en)
JP (1) JP4976636B2 (en)
KR (1) KR100572408B1 (en)
CN (1) CN100496579C (en)
AT (1) ATE372764T1 (en)
AU (1) AU2001267917A1 (en)
DE (1) DE60130466T2 (en)
TW (1) TWI290468B (en)
WO (1) WO2002007745A1 (en)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7571511B2 (en) 2002-01-03 2009-08-11 Irobot Corporation Autonomous floor-cleaning robot
US7972632B2 (en) 2003-02-28 2011-07-05 Unigen Pharmaceuticals, Inc. Identification of Free-B-Ring flavonoids as potent COX-2 inhibitors
US7108868B2 (en) 2002-03-22 2006-09-19 Unigen Pharmaceuticals, Inc. Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia
US20050142233A1 (en) 2002-03-27 2005-06-30 Hououdou Co., Ltd. Compositions for treating and/or preventing pollinosis
DE60328676D1 (en) 2002-04-30 2009-09-17 Unigen Pharmaceuticals Inc FORMULATION OF A MIXTURE OF FLAVONOIDS AND FLAVANES WITH FREE B RING AS A THERAPEUTIC AGENT
US8034387B2 (en) 2002-04-30 2011-10-11 Unigen, Inc. Formulation of a mixture of free-B-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments
US8945518B2 (en) 2002-04-30 2015-02-03 Unigen, Inc. Formulation of dual eicosanoid system and cytokine system inhibitors for use in the prevention and treatment of oral diseases and conditions
CN100594926C (en) 2002-06-13 2010-03-24 株式会社凤凰堂 Anti-microbial agent and anti-microbial composition
KR20040039663A (en) * 2002-11-04 2004-05-12 최도성 cosmectics for prerention and improvement of atopic dermatitis and manufacturing method therefor
AU2004228021B2 (en) 2003-04-04 2010-09-02 Unigen, Inc. Formulation of dual cycloxygenase (COX) and lipoxygenase (LOX) inhibitors for mammal skin care
CN1764468B (en) * 2003-04-11 2010-05-26 株式会社凤凰堂 Skin protecting composition
CN1832751B (en) * 2003-07-29 2010-05-26 株式会社凤凰堂 Periodontal disease therapeutic and/or preventive composition
FR2865643B1 (en) * 2004-01-29 2007-10-19 Oreal PROCESS FOR THE PREPARATION OF A COMPOSITION FOR THE COSMETIC TREATMENT OF KERATINIC MATERIALS FROM PRESSURIZED FLUID AND VEGETABLE SUBSTANCES
JP2006241018A (en) * 2005-03-01 2006-09-14 Hoodo:Kk Promoting agent of new hair growth, white hair preventing and/or treating agent, antipruritic composition, and wound healing accelerating agent
JP4703283B2 (en) 2005-06-20 2011-06-15 星製薬株式会社 Wound dressing and method for producing the same
KR100761248B1 (en) 2006-10-12 2007-10-04 주식회사 유니젠 Composition for treating atopic dermatitis comprising extracts of bamboo and scutellaria
JP2009040757A (en) * 2007-08-10 2009-02-26 Maruzen Pharmaceut Co Ltd Agent promoting laminin 5 production, agent normalizing dermal basement membrane, and agent promoting recovery of skin lesion
US20100034879A1 (en) * 2008-08-11 2010-02-11 Hilton Becker Hyaluronic acid product and method for treating lacerations and wounds in a living body
KR101270736B1 (en) 2010-05-12 2013-06-03 (주) 메디플랜 A composition comprising extract from herbal for improving pruritus
EP4324479A3 (en) 2012-08-21 2024-04-24 Sanofi Biotechnology Methods for treating or preventing asthma by administering an il-4r antagonist
EP3889181B1 (en) * 2012-09-07 2024-04-24 Regeneron Pharmaceuticals, Inc. An il-4r antagonist antibody for use in treating atopic dermatitis by administering
TWI697334B (en) 2013-06-04 2020-07-01 美商再生元醫藥公司 Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an il-4r inhibitor
RS59354B1 (en) 2013-06-21 2019-10-31 Sanofi Biotechnology Methods for treating nasal polyposis by administering an il-4r antagonist
TWI634900B (en) 2013-07-11 2018-09-11 再生元醫藥公司 Methods for treating eosinophilic esophagitis by administering an il-4r inhibitor
ES2973858T3 (en) 2014-02-28 2024-06-24 Regeneron Pharma Methods for treating skin infections by administering an IL-4R antagonist
JP6342211B2 (en) * 2014-05-08 2018-06-13 櫻井 静 Antibacterial agent
JP6317444B2 (en) 2014-07-15 2018-04-25 三井化学株式会社 Trauma treatment agent and trauma treatment material
JP6861630B2 (en) 2014-11-14 2021-04-21 サノフィ・バイオテクノロジー How to treat chronic sinusitis with nasal polyps by administration of IL-4R antagonist
CN105434919A (en) * 2015-12-04 2016-03-30 湖南中医药大学 Medicine composition treating deep-rooted boils, ice sores and carbuncle sores and preparation method and application thereof
US9949915B2 (en) 2016-06-10 2018-04-24 Clarity Cosmetics Inc. Non-comedogenic and non-acnegenic hair and scalp care formulations and method for use
MA46098A (en) 2016-09-01 2019-07-10 Regeneron Pharma METHODS FOR PREVENTING OR TREATING ALLERGY BY GIVING AN IL-4 R ANTAGONIST
GB2573933B (en) 2017-01-31 2022-07-13 Kimberly Clark Co Antibacterial composition including benzoic acid ester and methods of inhibiting bacterial growth utilizing the same
WO2019028367A1 (en) 2017-08-04 2019-02-07 Regeneron Pharmaceuticals, Inc. Methods for treating active eosinophilic esophagitis
MA46269B1 (en) 2017-08-18 2024-05-31 Regeneron Pharma METHODS OF TREATING SEVERE ATOPIC DERMATITIS BY ADMINISTRATION OF AN IL-4R INHIBITOR
CN111526920A (en) 2017-10-30 2020-08-11 赛诺菲生物技术公司 Methods of treating or preventing asthma by administering IL-4R antagonists
CN107898832A (en) * 2017-12-04 2018-04-13 大新县科学技术情报研究所 A kind of canarium pimela rusting vulnerary and preparation method thereof
BR112020020387A2 (en) 2018-05-13 2021-01-19 Regeneron Pharmaceuticals, Inc. METHODS FOR TREATING ATOPIC DERMATITIS BY ADMINISTERING AN IL-4R INHIBITOR
AU2020240132A1 (en) 2019-03-21 2021-09-16 Regeneron Pharmaceuticals, Inc. Combination of IL-4/IL-13 pathway inhibitors and plasma cell ablation for treating allergy
CN110169925A (en) * 2019-05-27 2019-08-27 甄旭东 A kind of anti-dandruff and itching-relieving composition and preparation method thereof
CN114173819A (en) 2019-08-05 2022-03-11 瑞泽恩制药公司 Methods of treating allergy and enhancing allergen-specific immunotherapy by administering IL-4R antagonists

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59104321A (en) * 1983-10-12 1984-06-16 T O C:Kk Preparation of medicinal substance from leaf of sasa albo-marginata
US5494667A (en) * 1992-06-04 1996-02-27 Kabushiki Kaisha Hayahibara Topically applied hair restorer containing pine extract
JPH10158177A (en) * 1996-11-28 1998-06-16 Kao Corp Restrainer of itching and/or pain
JPH11137640A (en) * 1997-11-14 1999-05-25 Nippon Iyakuhin Kogyo Kk Method for granulating crude medicines
JPH11199467A (en) * 1998-01-06 1999-07-27 Nonogawa Shoji Kk Skin preparation for external use
JP3253911B2 (en) * 1998-01-08 2002-02-04 眞悟 菊地 A method for efficiently extracting extracts from sasa leaves and culms
JP3212278B2 (en) * 1998-01-08 2001-09-25 眞悟 菊地 Manufacturing method and equipment for producing extract products from plants and mushrooms in a factory
JP2000044481A (en) * 1998-07-30 2000-02-15 Sunstar Inc Preparation for external use for skin
US6187324B1 (en) * 1998-08-11 2001-02-13 Kabushiki Kaisha Ogi Kogei Cosmetic composition comprising at least one of Kumazasa extract and medicinal carbon
JP4020282B2 (en) * 1998-10-27 2007-12-12 株式会社大和生物研究所 Skin oil / dirt paper products
US20050142233A1 (en) * 2002-03-27 2005-06-30 Hououdou Co., Ltd. Compositions for treating and/or preventing pollinosis
CN100594926C (en) * 2002-06-13 2010-03-24 株式会社凤凰堂 Anti-microbial agent and anti-microbial composition

Also Published As

Publication number Publication date
US20060029627A1 (en) 2006-02-09
KR20030047993A (en) 2003-06-18
DE60130466D1 (en) 2007-10-25
JP4976636B2 (en) 2012-07-18
WO2002007745A1 (en) 2002-01-31
EP1304115B1 (en) 2007-09-12
ATE372764T1 (en) 2007-09-15
TWI290468B (en) 2007-12-01
EP1304115A1 (en) 2003-04-23
KR100572408B1 (en) 2006-04-19
US20030113387A1 (en) 2003-06-19
CN100496579C (en) 2009-06-10
CN1466461A (en) 2004-01-07
EP1304115A4 (en) 2004-07-21
DE60130466T2 (en) 2008-06-12

Similar Documents

Publication Publication Date Title
AU2001267917A1 (en) Antipruritic compositions and compositions promoting wound healing
WO2003004000A3 (en) Topical composition for treating pain
DE69914726D1 (en) COMPOSITION FOR REGULATING THE SKIN APPEARANCE
WO1999058555A3 (en) Water-soluble pro-drugs of 2,6-diisopropylphenol analogues
WO2006034154A3 (en) Salts of 5-azacytidine
LT2004060A (en) A composition for treating neurocerebrovascular disorders
WO2004103294A3 (en) Methods and compositions for the prevention and treatment of sepsis
WO2006037024A3 (en) Salts of decitabine
EP2325651A3 (en) Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
WO2001058412A3 (en) Extracts from residues left in the production of wine
UA86599C2 (en) Substituted benzimidazole-, benztriazole- and benzimidazolone-о-glucosides
IL144297A0 (en) Composition for treating obesity and aesthetic treatment method
UA90668C2 (en) Composition for the treatment of chronic venous insufficiencies comprising an extract of red vine leaves and an anti-inflammatory agent
WO2005016455A3 (en) Antibodies against factor viii with modified glycosylation in the variable region
HUP0402291A2 (en) Stabilized azithromycin compositions, process for their preparation and pharmaceutical compositions containing them
WO2002007669A3 (en) Phospholipid derivatives of valproic acid and mixtures thereof
CA2070685A1 (en) Method for treating painful, inflammatory or allergic disorders
WO2003045334A3 (en) Methods and compositions for ameliorating the undesirable effects of chemotherapy
WO2006007538A3 (en) Composition and method for the treatment of asthma symptoms
PL1855692T3 (en) Compositions for treating skin diseases characterised by exudation of serum proteins
MY150686A (en) Oral composition containing morin
WO2003072053A3 (en) Compounds for treatment of copper overload
CA2433343A1 (en) Cosmetic compositions containing rosemary extract and dha
ATE486567T1 (en) ORAL COMPOSITION COMPRISING A FIRST COMPOSITION (A) AND A SECOND COMPOSITION (B) FOR USE AS MIXTURES FOR SEPARATE OR SEQUENTIAL USE IN COSMETIC TREATMENT OF THE HUMAN BODY
EP1122261A3 (en) 13 and 14-membered antibacterial macrolides